Often collaborating with its expansive international network, Herbert Smith Freehills Kramer LLP‘s team stands out for its handling of patent revocation and enforcement actions, in addition to issues surrounding patent validity. Frédéric Chevallier is recommended for his strong focus on patent litigation and regulatory issues within the pharma industry, often representing global pharma corporations.
Legal 500 Editorial commentary
- Profile
- Social
Key clients
- Sanofi
- Millennium Pharmaceuticals, Inc. (Takeda)
- Roche
- Foundation Medicine
- Janssen
Work highlights
- Advising Sanofi on four infringement actions started before the Unified Patent Court in relation to one of its innovative products, Jevtana®, for the treatment of prostate cancer (cabazitaxel).
- Representing Millennium Pharmaceuticals Inc., Takeda Pharmaceuticals and its exclusive licensee Janssen in the enforcement strategy of their patents, protecting their blockbuster bortezomib product against generic entry.
Lawyers
Practice head
Frédéric Chevallier